Vacuolar-type H+-ATPase (v-ATPase) complex (v-ATPase)

The Vacuolar-type H+-ATPase (v-ATPase) complex is a highly conserved, multi-subunit molecular machine that functions as an ATP-driven proton pump across biological membranes (Forgac, 2007; Marshansky & Futai, 2008). It consists of a peripheral V1 domain responsible for ATP hydrolysis and an integral V0 domain that translocates protons, effectively acidifying intracellular compartments such as lysosomes, endosomes, and the Golgi apparatus (Nishi & Forgac, 2002; Stransky et al., 2016). This acidification is critical for essential cellular processes, including receptor-mediated endocytosis, zymogen activation, and the secondary transport of small molecules like neurotransmitters (Forgac, 2007; Hinton et al., 2009). In specialized cells, v-ATPases are targeted to the plasma membrane to facilitate extracellular acidification, which is vital for bone resorption by osteoclasts and acid secretion by renal intercalated cells (Marshansky & Futai, 2008; Karet et al., 1999). Dysregulation of v-ATPase activity is implicated in various pathologies; for instance, its overexpression in cancer cells promotes an acidic microenvironment that enhances protease activity, leading to increased tumor invasion and metastasis (Hinton et al., 2009; Sennoune et al., 2004). Furthermore, mutations in specific subunits are linked to genetic disorders such as distal renal tubular acidosis and osteopetrosis (Marshansky & Futai, 2008; Karet et al., 1999). Consequently, the v-ATPase complex has emerged as a significant therapeutic target, with inhibitors like bafilomycins and archazolids being investigated for their potential anti-cancer, anti-viral, and anti-resorptive properties (Huss & Wieczorek, 2009; Menche et al., 2007). However, the ubiquitous nature of the enzyme presents challenges for drug development due to the risk of systemic toxicity (Bowman & Bowman, 2005).

Other names

Vacuolar proton pumpV-type ATPaseH+-transporting ATPaseV-ATPase

Inhibition of the V0 or V1 domain to prevent ATP-driven proton translocation across biological membranes, thereby disrupting organelle acidification and downstream signaling pathways.